The cell surface mucin MUC1 limits the severity of influenza A virus infection

Mucosal Immunology

Volumn 10, Issue 6, 2017, Pages 1581-1593

  McAuley, J L ^a   Corcilius, L ^b   Tan, H X ^a   Payne, R J ^b   McGuckin, M A ^c   Brown, L E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MUCIN 1; SIALIC ACID; MEMBRANE PROTEIN; N ACETYLNEURAMINIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EPITHELIUM CELL; FEMALE; GENE; GENE FUNCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA A; INFLUENZA A VIRUS; INNATE IMMUNITY; LUNG EPITHELIUM; MALE; MORTALITY RATE; MUC1 GENE; MUC13 GENE; MUC16 GENE; NONHUMAN; PRIORITY JOURNAL; VIRUS ATTACHMENT; VIRUS LOAD; A-549 CELL LINE; ANIMAL; C57BL MOUSE; CHO CELL LINE; CRICETULUS; DISEASE EXACERBATION; GENETICS; IMMUNOLOGY; INFLUENZA; KNOCKOUT MOUSE; METABOLISM; MOUSE; ORTHOMYXOVIRUS INFECTION; PROTEIN DOMAIN;

A549 CELLS; ANIMALS; CHO CELLS; CRICETULUS; DISEASE PROGRESSION; FEMALE; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUCIN-1; N-ACETYLNEURAMINIC ACID; ORTHOMYXOVIRIDAE INFECTIONS; PROTEIN DOMAINS;

EID: 85026880483     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2017.16     Document Type: Article

References (55)

1. Linden, S.K., Sutton, P., Karlsson, N.G., Korolik, V. & McGuckin, M.A. Mucins in the mucosal barrier to infection. Mucosal Immunol. 1, 183-197 (2008).
2. Ehre, C. et al. Overexpressing mouse model demonstrates the protective role of Muc5ac in the lungs. Proc. Natl Acad. Sci. USA 109, 16528-16533 (2012).
3. Mata, M., Morcillo, E., Gimeno, C. & Cortijo, J. N-acetyl-L-cysteine (NAC) inhibit mucin synthesis and pro-inflammatory mediators in alveolar type II epithelial cells infected with influenza virus A and B and with respiratory syncytial virus (RSV). Biochem. Pharmacol. 82, 548-555 (2011).
4. Buchweitz, J.P., Harkema, J.R. & Kaminski, N.E. Time-dependent airway epithelial and inflammatory cell responses induced by influenza virus A/PR/ 8/34 in C57BL/6 mice. Toxicol. Pathol. 35, 424-435 (2007).
5. Rose, M.C. & Voynow, J.A. Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol. Rev. 86, 245-278 (2006).
6. Altschuler, Y. et al. Clathrin-mediated endocytosis of MUC1 is modulated by its glycosylation state. Mol. Biol. Cell 11, 819-831 (2000).
7. Mukherjee, P., Tinder, T.L., Basu, G.D. & Gendler, S.J. MUC1 (CD227) interacts with lck tyrosine kinase in Jurkat lymphoma cells and normal T cells. J. Leukoc. Biol. 77, 90-99 (2005).
8. Lillehoj, E.P., Kim, H., Chun, E.Y. & Kim, K.C. Pseudomonas aeruginosa stimulates phosphorylation of the airway epithelial membrane glycoprotein Muc1 and activates MAP kinase. Am. J. Physiol. Lung Cell Mol. Physiol. 287, L809-L815 (2004).
9. Wang, H., Lillehoj, E.P. & Kim, K.C. MUC1 tyrosine phosphorylation activates the extracellular signal-regulated kinase. Biochem. Biophys. Res. Commun. 321, 448-454 (2004).
10. Meerzaman, D., Shapiro, P.S. & Kim, K.C. Involvement of the MAP kinase ERK2 in MUC1 mucin signaling. Am. J. Physiol. Lung Cell Mol. Physiol. 281, L86-L91 (2001).
11. Rahn, J.J., Shen, Q., Mah, B.K. & Hugh, J.C. MUC1 initiates a calcium signal after ligation by intercellular adhesion molecule-1. J. Biol. Chem. 279, 29386-29390 (2004).
12. Ueno, K. et al. MUC1 mucin is a negative regulator of toll-like receptor signaling. Am. J. Respir. Cell Mol. Biol. 38, 263-268 (2008).
13. Li, Y.,Dinwiddie, D.L., Harrod, K.S., Jiang, Y.& Kim, K.C. Anti-inflammatory effect of MUC1 during respiratory syncytial virus infection of lung epithelial cells in vitro. Am. J. Physiol. Lung Cell Mol. Physiol. 298, L558-L563 (2010).
14. Kato, K., Lillehoj, E.P. & Kim, K.C. Pseudomonas aeruginosa stimulates tyrosine phosphorylation of and TLR5 association with the MUC1 cytoplasmic tail through EGFR activation. Inflamm. Res. 65, 225-233 (2016).
15. Kato, K. et al. Membrane-tethered MUC1 mucin is phosphorylated by epidermal growth factor receptor in airway epithelial cells and associates with TLR5 to inhibit recruitment of MyD88. J. Immunol. 188, 2014-2022 (2012).
16. Kim, K.C. & Lillehoj, E.P. MUC1 mucin: a peacemaker in the lung. Am. J. Respir. Cell Mol. Biol. 39, 644-647 (2008).
17. Yen, J.H., Xu, S., Park, Y.S., Ganea, D. & Kim, K.C. Higher susceptibility to experimental autoimmune encephalomyelitis in Muc1-deficient mice is associated with increased Th1/Th17 responses. Brain Behav. Immun. 29, 70-81 (2013).
18. Gaemers, I.C., Vos, H.L., Volders, H.H., van der Valk, S.W. & Hilkens, J. A stat-responsive element in the promoter of the episialin/MUC1 gene is involved in its overexpression in carcinoma cells. J. Biol. Chem. 276, 6191-6199 (2001).
19. Kato, K., Lillehoj, E.P. & Kim, K.C. MUC1 regulates epithelial inflammation and apoptosis by PolyI:C through inhibition of Toll/IL-1 receptor-domaincontaining adapter-inducing IFN-beta (TRIF) recruitment to Toll-like receptor 3. Am. J. Respir. Cell Mol. Biol. 51, 446-454 (2014).
20. Ng, G.Z. et al. The MUC1 mucin protects against Helicobacter pylori pathogenesis in mice by regulation of the NLRP3 inflammasome. Gut 65, 1087-1099 (2015).
21. Hattrup, C.L. & Gendler, S.J. Structure and function of the cell surface (tethered) mucins. Annu. Rev. Physiol. 70, 431-457 (2008).
22. Manders, E., Verbeek, F. & Aten, J. Measurement of co-localization of objects in dual-colour confocal images. J. Microsc. 169, 375-382 (1993).
23. Kumari, K., Gulati, S., Smith, D.F., Gulati, U., Cummings, R.D. & Air, G.M. Receptor binding specificity of recent human H3N2 influenza viruses. Virol. J. 4, 42 (2007).
24. McAuley, J.L. et al. MUC1 cell surface mucin is a critical element of the mucosal barrier to infection. J. Clin. Invest. 117, 2313-2324 (2007).
25. Lillehoj, E.P. et al. Muc1 mucins on the cell surface are adhesion sites for Pseudomonas aeruginosa. Am. J. Physiol. Lung Cell Mol. Physiol. 280, L181-L187 (2001).
26. Linden, S.K. et al. MUC1 limits Helicobacter pylori infection both by steric hindrance and by acting as a releasable decoy. PLoS Pathog. 5, e1000617 (2009).
27. Arcasoy, S.M. et al. MUC1 and other sialoglycoconjugates inhibit adenovirus-mediated gene transfer to epithelial cells. Am. J. Respir. Cell Mol. Biol. 17, 422-435 (1997).
28. Kim, Y.S., Gum, J. Jr & Brockhausen, I. Mucin glycoproteins in neoplasia. Glycoconj. J. 13, 693-707 (1996).
29. Guarner, J. & Falcon-Escobedo, R. Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses. Arch. Med. Res. 40, 655-661 (2009).
30. Bordon, J. et al. Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia. Int. J. Infect. Dis. 17, e76-e83 (2013).
31. McAuley, J.L., Chipuk, J.E., Boyd, K.L., Van De Velde, N., Green, D.R. & McCullers, J.A. PB1-F2 proteins from H5N1 and 20 century pandemic influenza viruses cause immunopathology. PLoS Pathog. 6, e1001014 (2010).
32. McAuley, J.L. et al. Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe 2, 240-249 (2007).
33. McAuley, J.L. et al. Activation of the NLRP3 inflammasome by IAV virulence protein PB1-F2 contributes to severe pathophysiology and disease. PLoS Pathog. 9, e1003392 (2013).
34. Sheng, Y.H. et al. MUC1 and MUC13 differentially regulate epithelial inflammation in response to inflammatory and infectious stimuli. Mucosal Immunol. 6, 557-568 (2012).
35. Umehara, T., Kato, K., Park, Y.S., Lillehoj, E.P., Kawauchi, H. & Kim, K.C. Prevention of lung injury by Muc1 mucin in a mouse model of repetitive Pseudomonas aeruginosa infection. Inflamm. Res. 61, 1013-1020 (2012).
36. Ibricevic, A. et al. Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells. J. Virol. 80, 7469-7480 (2006).
37. Kim, K.C. Role of epithelial mucins during airway infection. Pulm. Pharmacol. Ther. 25, 415-419 (2012).
38. Kesimer, M. et al. Characterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defense. FASEB J. 23, 1858-1868 (2009).
39. Gamblin, S.J. & Skehel, J.J. Influenza hemagglutinin and neuraminidase membrane glycoproteins. J. Biol. Chem. 285, 28403-28409 (2010).
40. Nguyen, Y., Procario, M.C., Ashley, S.L., O'Neal, W.K., Pickles, R.J. & Weinberg, J.B. Limited effects of Muc1 deficiency on mouse adenovirus type 1 respiratory infection. Virus Res. 160, 351-359 (2011).
41. Benne, C.A. et al. Interactions of surfactant protein A with influenza A viruses: binding and neutralization. J. Infect. Dis. 171, 335-341 (1995).
42. Reading, P.C. et al. Antiviral activity of the long chain pentraxin PTX3 against influenza viruses. J. Immunol. 180, 3391-3398 (2008).
43. Lillehoj, E.P. et al. NEU1 Sialidase Regulates Membrane-tethered Mucin (MUC1) Ectodomain Adhesiveness for Pseudomonas aeruginosa and Decoy Receptor Release. J. Biol. Chem. 290, 18316-18331 (2015).
44. Kyo, Y. et al. Antiinflammatory role of MUC1 mucin during infection with nontypeable Haemophilus influenzae. Am. J. Respir. Cell Mol. Biol. 46, 149-156 (2012).
45. Sheng, Y.H. et al. MUC13 protects colorectal cancer cells from death by activating the NF-kappaB pathway and is a potential therapeutic target. Oncogene 36, 700-713 (2016).
46. Sheng, Y.H. et al. TheMUC13cell-surface mucin protects against intestinal inflammation by inhibiting epithelial cell apoptosis. Gut 60, 1661-1670 (2011).
47. Shirai, K. et al. Effects of the loss of conjunctival Muc16 on corneal epithelium and stroma inmice. Invest. Ophthalmol. Vis. Sci. 55, 3626-3637 (2014).
48. Milara, J., Morell, A., Ballester, B., Armengot, M., Morcillo, E. & Cortijo, J. MUC4impairs the anti-inflammatory effects ofcorticosteroids inpatientswith chronic rhinosinusitis with nasal polyps. J. Allergy Clin. Immunol. (2016) (in press).
49. Shoemaker, J.E. et al. An ultrasensitive mechanism regulates influenza virus-induced inflammation. PLoS Pathog. 11, e1004856 (2015).
50. Tan, H.X. et al. Recombinant influenza virus expressing HIV-1 p24 capsid protein induces mucosal HIV-specific CD8 T-cell responses. Vaccine 34, 1172-1179 (2016).
51. Szretter, K.J., Balish, A.L. & Katz, J.M. Influenza: propagation, quantification, and storage. Curr. Protoc. Microbiol. Chapter 15, Unit 15G 11 (2006).
52. Xing, P.X., Prenzoska, J. & McKenzie, I.F. Epitope mapping of anti-breast and anti-ovarian mucin monoclonal antibodies. Mol. Immunol. 29, 641-650 (1992).
53. Sheng, Y.H., Hasnain, S.Z., Png, C.W., McGuckin, M.A. & Linden, S.K. Techniques for assessment of interactions of mucins with microbes and parasites in vitro and in vivo. Methods Mol. Biol. 842, 297-312 (2012).
54. Harrop, C.A., Thornton, D.J. & McGuckin,M.A. Detecting, visualising, and quantifying mucins. Methods Mol. Biol. 842, 49-66 (2012).
55. Corcilius, L. & Payne, R.J. Stereoselective synthesis of sialylated tumorassociated glycosylamino acids. Org. Lett. 15, 5794-5797 (2013).